LOADING
Comparing AbbVie Inc (ABBV) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $414.8B | $233.9B |
| P/E Ratio | 115.1 | 23.9 |
| Forward P/E | 16.5 | 20.7 |
| PEG Ratio | 0.65 | 0.94 |
| EPS | $2.04 | $9.29 |
| Revenue Growth (YoY) | 12.4% | -3.5% |
| Profit Margin | 5.8% | 22.3% |
| Return on Equity | 62.3% | 36.1% |
| Dividend Yield | 2.93% | 1.57% |
| Beta | 0.31 | 1.60 |
| 52-Week High | $239.13 | $258.96 |
| 52-Week Low | $176.00 | $121.54 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.